Cargando…

Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs

BACKGROUND: Human parathyroid hormone (PTH) (1-34) or teriparatide (TPTD) is an anabolic agent for osteoporosis. This recombinant protein stimulates positive bone formation balance and bone remodeling. However, when concomitantly used with antiresorptive (AR) agents, previous studies reported confli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jiefu, Jing, Zhizhen, Chang, Feng, Li, Lijun, Su, Yunxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271803/ https://www.ncbi.nlm.nih.gov/pubmed/25503108 http://dx.doi.org/10.12659/MSM.892581

Ejemplares similares

Pancreatogastrostomy vs pancreatojejunostomy after pancreaticoduodenectomy: An updated meta-analysis of RCTs and our experience
por: Jin, Yun, et al.
Publicado: (2019)

Early Enteral Nutrition within 24 Hours or between 24 and 72 Hours for Acute Pancreatitis: Evidence Based on 12 RCTs
por: Li, Xueping, et al.
Publicado: (2014)

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
por: Pearson, Richard G., et al.
Publicado: (2019)

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
por: Satterwhite, Julie, et al.
Publicado: (2010)

Effect of WeChat‐based continuous care intervention on the somatic function, depression, anxiety, social function and cognitive function for cancer patients: Meta‐analysis of 18 RCTs
por: Wang, Zhuoxin, et al.
Publicado: (2023)

The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis
por: Yamaguchi, Yuta, et al.
Publicado: (2020)

Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
por: Pietrogrande, Luca
Publicado: (2010)

Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis
por: Shen, Jiping, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism
por: Tng, Eng-Loon, et al.
Publicado: (2020)

Bone material strength is associated with areal BMD but not with prevalent fractures in older women
por: Rudäng, R., et al.
Publicado: (2015)

Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta‐Analysis of the Osteoporotic Fractures in Men (MrOS) Study
por: Harvey, Nicholas C, et al.
Publicado: (2018)

Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis
por: Zhao, Huawei, et al.
Publicado: (2022)

Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors
por: Crowell, Cameron, et al.
Publicado: (2022)

Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis
por: Chen, Shanshan, et al.
Publicado: (2022)

Sex, Race, and Age Differences of Cardiovascular Outcomes in Cardiac Resynchronization Therapy RCTs: A Systematic Review and Meta-analysis
por: McKay, Bradley, et al.
Publicado: (2021)

Impacts of Exercise Interventions on Inflammatory Markers and Vascular Adhesion Molecules in Patients With Heart Failure: A Meta-analysis of RCTs
por: Malandish, Abbas, et al.
Publicado: (2023)

Bone microstructure in men assessed by HR-pQCT: Associations with risk factors and differences between men with normal, low, and osteoporosis-range areal BMD
por: Okazaki, Narihiro, et al.
Publicado: (2016)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Time course of 25(OH)D(3 )vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD)
por: Wölfl, Christoph, et al.
Publicado: (2013)

Efficacy and safety of recombinant human parathyroid hormone (1–34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
por: Deng, Jing, et al.
Publicado: (2018)

Correlations Between Abnormal Glucose Metabolism and Bone Mineral Density or Bone Metabolism
por: Qu, Yang, et al.
Publicado: (2016)

Association of HLA-DRB1 Gene Polymorphism with Risk of Asthma: A Meta-Analysis
por: Yao, Yingshui, et al.
Publicado: (2016)

Comparative efficacy and safety of NSAIDs-controlled acupuncture in the treatment of patients with primary dysmenorrhoea: a Bayesian network meta-analysis
por: Luo, Falan, et al.
Publicado: (2018)

Association between essential hypertension and bone mineral density: a systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017)

Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment
por: Fowler, Tristan W., et al.
Publicado: (2012)

Associations between bone mineral density and coronary artery calcification: a systematic review and meta-analysis
por: Zhang, Peiyu, et al.
Publicado: (2022)

Correction: Time Course of 25(OH)D(3) vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral denisty (BMD)
por: Wölfl, Christoph, et al.
Publicado: (2014)

Parathyroid hormone PTH(1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits
por: Aleksyniene, Ramune, et al.
Publicado: (2009)

Robot-Assisted Radical Prostatectomy Is More Beneficial for Prostate Cancer Patients: A System Review and Meta-Analysis
por: Du, Yuefeng, et al.
Publicado: (2018)

Association Between Head and Neck Cancers and Polymorphisms 869T/C, 509C/T, and 915G/C of the Transforming Growth Factor-β1 Gene: A Meta-Analysis of Case-Control Studies
por: Qu, Yanli, et al.
Publicado: (2019)

T2*-corrected Q-Dixon and reduced-FOV diffusion kurtosis imaging (DKI) parameters: correlation with QCT-derived bone mineral density (BMD) and ability to identify abnormal BMD and osteoporosis in postmenopausal women
por: Li, Xiangwen, et al.
Publicado: (2023)

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
por: Salave, Sagar, et al.
Publicado: (2023)

Relationship Among Panoramic Radiography Findings, Biochemical Markers of Bone Turnover and Hip BMD in the Diagnosis of Postmenopausal Osteoporosis
por: Johari Khatoonabad, M., et al.
Publicado: (2011)

Attenuation of Alzheimer’s brain pathology in 5XFAD mice by PTH(1-34), a peptide of parathyroid hormone
por: Chen, Li, et al.
Publicado: (2023)

Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
por: Medas, Fabio, et al.
Publicado: (2019)

Traditional Chinese Medicine for non-motor symptoms in Parkinson disease: A systematic review and meta-analysis of RCTs
por: Huang, Liqing, et al.
Publicado: (2023)

Selected Trends in Psychotherapy Research: An Index Analysis of RCTs
por: Rief, Winfried, et al.
Publicado: (2022)

PTH [1–34] induced differentiation and mineralization of mandibular condylar cartilage
por: O’ Brien, Mara Heather, et al.
Publicado: (2017)

Plasma gelsolin is associated with hip BMD in Chinese postmenopausal women
por: Wang, Wen-Yu, et al.
Publicado: (2018)

Association of vitamin D, BMD and knee osteoarthritis in postmenopausal women
por: Zafeiris, Evangelos P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8sjq3e1m77uf9uc07mhr4nem2v